Bexagliflozin Tablet
Product Images NDC 51407-918

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Bexagliflozin (NDC 51407-918). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

51407-918-30ol (Bexagliflozin Tablets)

51407-918-30ol (Bexagliflozin Tablets)
Label for Bexagliflozin 20 mg tablets by Golden State Medical Supply, Inc. The label includes the product name, dosage strength, and quantity of 30 tablets. It provides dosage warnings such as not crushing or chewing tablets and storage instructions at 20°-25°C. Contains a barcode, QR code, lot, expiration, and serial number sections, and directs pharmacists to dispense the medication guide.*
FDA Label Image

Bexagliflozin Pi- Chart_page_1.jpg (Bexagliflozin Pi Chart Page 1)

Bexagliflozin Pi- Chart_page_1.jpg (Bexagliflozin Pi  Chart Page 1)
A line graph depicting the mean percentage change over 24 weeks, comparing Bexagliflozin and placebo groups. The x-axis represents weeks, including a Week 24 RTB point, while the y-axis shows mean change in percentage. Bexagliflozin demonstrates a decreasing trend, whereas placebo remains near zero throughout the timeline, with error bars indicating variability at each time point.*
FDA Label Image

Bexagliflozin-figure-1 (Bexagliflozin Figure 1)

Bexagliflozin-figure-1 (Bexagliflozin Figure 1)
A chart showing the geometric mean ratio with 90% confidence intervals (CI) for various drugs including Metformin, Glimepiride, Sitagliptin, Exenatide, Probenecid, Verapamil, and Rifampin. The graph compares AUC and Cmax values for each drug, illustrating relative pharmacokinetic measures.*
FDA Label Image

Bexagliflozin-figure-2 (Bexagliflozin Figure 2)

Bexagliflozin-figure-2 (Bexagliflozin Figure 2)
A forest plot chart illustrating the geometric mean ratio with 90% confidence intervals for Bexagliflozin drug exposure (AUC and Cmax) when coadministered with other drugs: Metformin 1000 mg, Glimepiride 2 mg, Sitagliptin 100 mg, and Digoxin 0.5 mg. Each drug's AUC and Cmax values with confidence intervals are displayed relative to a reference line at 100.*
FDA Label Image

Bexagliflozin-structure (Bexagliflozin Structure)

Bexagliflozin-structure (Bexagliflozin Structure)
Chemical structure diagram of Bexagliflozin, showing its molecular arrangement with hydroxyl groups, a chlorine-substituted aromatic ring, and ether linkages.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.